Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Anticancer Research

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.21873/ANTICANRES.11967PMID 28982849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sphingosine 1-phosphate and cancer.

  2017cited by this paper
• Stromal p16 Overexpression in Adult Granulosa Cell Tumors of the Ovary.

  2017cited by this paper
• Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer

  2017cited by this paper
• Overexpression of sphingosine kinase 1 is predictive of poor prognosis in human breast cancer

  2017cited by this paper
• Chemotherapy-induced endometrial pathology: mimicry of malignancy and viral endometritis.

  2016cited by this paper
• Clinical outcomes of advanced-stage glassy cell carcinoma of the uterine cervix: a need for reappraisal

  2016cited by this paper
• Stromal p16 expression is significantly increased in endometrial carcinoma

  2016cited by this paper
• Stromal p16 expression is significantly increased in malignant ovarian neoplasms

  2016cited by this paper
• Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast.

  2016cited by this paper
• Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.

  2015cited by this paper
• Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer

  2015cited by this paper
• Increased SPHK1 expression is associated with poor prognosis in bladder cancer

  2014cited by this paper
• Sphingosine Kinase 1 Promotes Malignant Progression in Colon Cancer and Independently Predicts Survival of Patients With Colon Cancer by Competing Risk Approach in South Asian Population

  2014cited by this paper
• The Impact of Sphingosine Kinase-1 in Head and Neck Cancer

  2013cited by this paper
• Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.

  2012cited by this paper
• Sphingosine 1-phosphate signalling in cancer.

  2012cited by this paper
• Sphingosine kinase 1 is overexpressed and promotes proliferation in human thyroid cancer.

  2011cited by this paper
• Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy

  2011cited by this paper
• An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma

  2011cited by this paper
• Sphingosine 1-phosphate and cancer

  2010cited by this paper
• Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy

  2010cited by this paper
• The Expression of Sphingosine Kinase-1 in Head and Neck Carcinoma

  2010cited by this paper
• Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens.

  2010cited by this paper
• Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients

  2009cited by this paper
• Prognostic Factors Affecting Neck Lymph Node Recurrence and Distant Metastasis in Papillary Microcarcinoma of the Thyroid: Results of a Study in 445 Patients

  2009cited by this paper
• Role for sphingosine kinase 1 in colon carcinogenesis

  2009cited by this paper
• Lipid signalling in disease

  2008cited by this paper
• Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival

  2008cited by this paper
• Prognostic significance of lymph node metastases and ratio in esophageal cancer.

  2008cited by this paper
• Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions

  2008cited by this paper
• Increasing Incidence of Thyroid Cancer in the United States, 1973–2002Davies L, Welch HG (Dept of Veterans Affairs Med Ctr, White River Junction, Vt; Darmouth Med School, Hanover, NH) JAMA 295:2164–2167, 2006§

  2007cited by this paper
• Risk Factors for Recurrence to the Lymph Node in Papillary Thyroid Carcinoma Patients without Preoperatively Detectable Lateral Node Metastasis: Validity of Prophylactic Modified Radical Neck Dissection

  2007cited by this paper
• Increasing incidence of thyroid cancer in the United States, 1973-2002.

  2006cited by this paper
• Intracellular Role for Sphingosine Kinase 1 in Intestinal Adenoma Cell Proliferation

  2006cited by this paper
• Sphingosine Kinase-1 Expression Correlates With Poor Survival of Patients With Glioblastoma Multiforme: Roles of Sphingosine Kinase Isoforms in Growth of Glioblastoma Cell Lines

  2005cited by this paper
• Immunohistochemical Distribution of Sphingosine Kinase 1 in Normal and Tumor Lung Tissue

  2005cited by this paper
• Clinicopathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer.

  2001cited by this paper
• Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996

  2000cited by this paper
• Multivariate analysis of histopathological features as prognostic factors in patients with papillary thyroid carcinoma

  1995cited by this paper
• Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

  1994cited by this paper
• Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer

  1994cited by this paper
• Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients.

  1987cited by this paper

• Blood metabolites reflect the effect of gut microbiota on differentiated thyroid cancer: a Mendelian randomization analysis

  2025cites this paper
• Clinicopathological and Prognostic Significance of Programmed Death Ligand 1 Expression in Korean Patients With Triple-negative Breast Carcinoma

  2020cites this paper
• CCNA1 gene as a potential diagnostic marker in papillary thyroid cancer.

  2020cites this paper
• Endometrium-Limited Metastasis of Extragenital Malignancies: A Challenge in the Diagnosis of Endometrial Curettage Specimens

  2020cites this paper
• Association of serum sphingomyelin profile with clinical outcomes in patients with lower respiratory tract infections: results of an observational, prospective 6-year follow-up study

  2019cites this paper
• Oncometabolites as biomarkers in thyroid cancer: a systematic review

  2019cites this paper
• Clinicopathological Characteristics of High-grade Squamous Intraepithelial Lesions Involving Condyloma Acuminatum.

  2018cites this paper
• Lower Sympathetic Nervous System Density and β-adrenoreceptor Expression Are Involved in Gastric Cancer Progression

  2018cites this paper
• Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.

  2018cites this paper
• Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.

  2018cites this paper
• Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix

  2018cites this paper
• Expression of Zinc Finger and BTB Domain-containing 7A in Colorectal Carcinoma.

  2018cites this paper
• Clinicopathological Characteristics of Ovarian Metastasis from Colorectal and Pancreatobiliary Carcinomas Mimicking Primary Ovarian Mucinous Tumor

  2018cites this paper